Skip to content

Compressive Stockings Therapy After TKA

Effect of Compliance Controlled Postoperative Compressive Stockings Therapy After Total Knee Arthroplasty: a Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04434222
Enrollment
20
Registered
2020-06-16
Start date
2019-02-01
Completion date
2022-05-30
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compliance of Wearing of Compressive Stockings, Total Knee Arthroplasty

Brief summary

Due to swelling after total knee arthroplasty, postoperative mobilization and training is impeded in addition to higher pain level in patients. With postoperative compressive stockings to prevent oedema, haematoma and postoperative pain we would like to investigate if compressive stockings reduce postoperative swelling and pain and furthermore improve mobilization and knee function. In this randomized controlled trial, 88 patients are randomized in two groups. One group receives postoperatively compressive stockings for a period of 6 weeks. The control group is treated without compressive stockings. The patients compressive stockings wearing compliance is controlled with a temperature sensitive sensor. The patients will be informed about the implantation of the sensor. Outcome measures are knee- calf- and ankle swelling in mm, pain, WOMAC and KSS score preoperatively and at 12 weeks, 12 months and 24 months.

Interventions

DEVICECompressive stockings

Compressive stockings with built in Orthotimer Sensor

Sponsors

Balgrist University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients receiving a total knee replacement * Written consent of the study participant

Exclusion criteria

* Peripheral arterial disease II, III or IV * Diabetes mellitus * Systemic inflammatory diseases * Benign or malignant neoplasms * Revision interventions * Right heart failure * pulmonary edema * Open / chronic skin lesions

Design outcomes

Primary

MeasureTime frameDescription
Pain 1 year postoperative1 year postoperativeVisuelle Analogskala - VAS (1-10)
Knee Function WOMAC 12 weeks postoperative12 weeks postoperativeWestern Ontario and McMaster Universities Osteoarthritis Index - WOMAC
Knee Function WOMAC 1 year postoperative1 year postoperativeWestern Ontario and McMaster Universities Osteoarthritis Index - WOMAC
Pain 6 weeks postoperative6 weeks postoperativeVisuelle Analogskala - VAS (1-10)
Pain 12 weeks postoperative12 weeks postoperativeVisuelle Analogskala - VAS (1-10)
Knee Function KSS 6 weeks postoperative6 weeks postoperativeKnee Society Score - KSS
Knee Function KSS 12 weeks postoperative12 weeks postoperativeKnee Society Score - KSS
Knee Function KSS 1 year postoperative1 year postoperativeKnee Society Score - KSS
Knee Function WOMAC 6 weeks postoperative6 weeks postoperativeWestern Ontario and McMaster Universities Osteoarthritis Index - WOMAC

Secondary

MeasureTime frameDescription
Swelling 12 weeks postoperative12 weeks postoperativeSwelling in mm
Swelling 1 year postoperative1 year postoperativeSwelling in mm
Compliance first 6 weeks postoperativFirst 6 weeks postoperativMeasured with Orthotimer sensor
Swelling 6 weeks postoperative6 weeks postoperativeSwelling in mm

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026